The largest database of trusted experimental protocols

151 protocols using cysteamine

1

Assessing ARPE-19 Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
ARPE-19 cells were grown on a 96 well plate overnight and then exposed to room-air or CSE (50%) with appropriate treatments of cysteamine (250μM, Sigma) or fisetin (40 μM, Sigma) for 24 hours. Cells were the incubated with 1.2 mM MTS (Life Technologies) reagent for 1 hour at 37°C and 5% CO2. Absorbance was then measured at 490 nm and data analyzed by SoftMax Pro 6.0 analysis software. For the assessment of cell viability using propidium iodide (PI) staining, cells were exposed to room-air or CSE (50%) and/or parallel treatments with cysteamine (250μM, Sigma) or fisetin (40 μM, Sigma) for 12 hours. The cells were harvested, washed with PBS (2x) and incubated with PI staining solution (10 μg/ml), and data was immediately acquired using the BD FACSAria flow cytometer using the FL2 (PE) channel. Subsequently, data was analyzed using the BD FACSDiva software as we previously described [24 (link), 25 (link)].
+ Open protocol
+ Expand
2

Autophagy modulation in ARPE-19 cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
ARPE-19 cells were transiently co-transfected with ubiquitin-RFP and LC3-GFP plasmids using Lipofectamine® 2000 (Invitrogen, 24 hours) in a 24 well plate, and treated with 10% CSE, cysteamine (250 μM, Sigma), or fisetin (40 μM, Sigma) for 12 hours. Images were captured using the ZOEFluorescent Cell Imager (Bio-Rad). For the autophagy flux assay, ARPE-19 cells were transiently transfected with the Premo Autophagy Tandem Sensor RFP-GFP-LC3B (Thermo Fisher) plasmid in a 24 well plate for 12 hours as described recently [24 (link), 25 (link)], and then subsequently treated with 10% CSE and/or cysteamine (250 μM, Sigma), for 12 hours. Images were captured using the ZOEFluorescent Cell Imager (Bio-Rad).
+ Open protocol
+ Expand
3

Detailed Thymosin α1 Peptide Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gaslini Laboratory: Tα-1 peptides were purchased from CRIBI (CRIBI Biotechnology Center, Peptide Facility, Università di Padova, Italy) and from Abcam (cat. #ab42247). Thymosin α1 peptides were dissolved at 2 mg/ml in either DMSO or ddH2O, VX-809 (SelleckChem, S1565) was solubilised in DMSO (10 mM), cysteamine (Sigma, M9768) was freshly solubilised in aqueous solution at the desired final concentration.
McGill Laboratory: Thymosin α1 (abcam, ab42247) was reconstituted in 0.1% acetic acid, VX-809 (Selleck, S1565) was solubilised in DMSO, cysteamine (Sigma, M9768) was freshly solubilised in aqueous solution, and epigallocatechin gallate (EGCG, Sigma, E4143) was solubilised in ethanol.
UCSF Laboratory: VX-809, VX-770 and CFTRinh-172 were purchased from Selleck Chemicals (Boston, MA). Human Thymosin alpha-1 peptide (ab42247) were purchased from Abcam (Cambridge, MA).
+ Open protocol
+ Expand
4

Quantifying Cysteamine Reactivity

Check if the same lab product or an alternative is used in the 5 most similar protocols
As the thiol donor, cysteamine (Sigma–Aldrich, Burlington, MA, USA) aqueous (10 mmol/L) was diluted with 100 mmol/L phosphate buffer (pH 7.4) to make 1 × cysteamine solution (0.5 mmol/L). The stock solution of test compounds was diluted with 100 mmol/L phosphate buffer (pH 7.4) to a given concentration. For preparation of DTNB regent, 0.014 mmol DTNB (Sigma–Aldrich) and 0.5 mmol sodium hydrogen carbonate was dissolved in 25 mL of 100 mmol/L phosphate buffer (pH 7.4). cysteamine solution (0.5 mmol/L) was mixed with an equal volume of test compound solution, and quickly transferred into a 96-well plate. At different time points, reduced thiol groups were quantified with DTNB. One minute after DTNB was added, the absorption was measured at λ = 405 nm using a Synergy H1 microplate reader (BioTek, Winooski, Vermont, USA). The quantification of the remaining cysteamine was carried out by the calibration curve of thiol content vs. absorbance.
+ Open protocol
+ Expand
5

Graphene-Based FET for Metal Ion Sensing

Check if the same lab product or an alternative is used in the 5 most similar protocols
A monolayer graphene film was produced by CVD (Supplementary Note 1) and transferred onto a clean SiO2/Si substrate to fabricate a FET device by photolithography. The device was thermally annealed to improve the contacts between graphene and electrodes (50 nm Au/5 nm Cr), and then Au NPs were deposited onto graphene by vacuum evaporation (Covap, Angstrom Corp.) and thermal annealing at 200 °C for 30 min. The resulting graphene/Au NPs was submerged in 10−2 M cysteamine (Sigma-Aldrich) solution. The assembly of cysteamine on Au NPs was kept overnight at room temperature, followed by rinsing with ethanol for several times to remove extra cysteamine. The cysteamine-modified device was immersed in 10−5 M PP (Sigma-Aldrich) and N,N-dimethylformamide (DMF) solution for 15 h, by adding 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (Sigma-Aldrich) and N-hydroxysuccinimide (Sigma-Aldrich) as the catalysts. The resulting FET sensor, with immobilized PP, was rinsed with DMF, acetone, ethanol, and distilled water in sequence to remove extra residues. The graphene/Au/Cys-PP was dipped in Cd2+, Zn2+, or Mg2+ solution for 6 h before tests. Owing to the coordination reaction with PP, Cd2+, Zn2+, or Mg2+ was bound to the surface of FET to charge-dope graphene. A solution chamber, which was employed in all solution-based measurements, was fabricated by a three-dimensional printer.
+ Open protocol
+ Expand
6

Super-Resolution Imaging of Single Molecules

Check if the same lab product or an alternative is used in the 5 most similar protocols
dSTORM imaging was performed using an Elyra PS.1 microscope (Carl Zeiss Microscopy) equipped with a Plan-Apochromat 100×/1.46 oil objective and a liquid cooled EMCCD camera (Andor Technology). Imaging was carried out in MEA imaging buffer as previously described (36 (link)). In short, fresh stock solutions (1 M cysteamine in 360 mM HCl, 10% glucose in PBS, 70 mg/ml glucose oxidase in PBS, and 20 mg/ml catalase in PBS) were prepared the day before imaging and stored at 4°C and mixed directly before imaging to final concentrations of 0.124 M cysteamine (Sigma), 44.8 mM HCl, 8.6% glucose, 1.08 mg/ml glucose oxidase from Aspergillus niger (Sigma), and 0.0773 mg/ml catalase from bovine liver (Sigma) in PBS. Imaging was performed in 12.8 × 12.8-μm areas in an inclined total internal reflection fluorescence microscope mode (37 (link)). Single molecule fluorescence detection on the EMCCD camera was acquired with 100 × 100-nm pixel size, 20-ms Exposure time, and 100 Gain. 20,000 image frames were acquired for each channel. Both channels were imaged sequentially in 500 frame sequences and the appropriate filters and lasers for each dye were used (642 nm for Alexa Fluor 647 and 488 nm for Atto 488). The images were analyzed with the ImageJ plugin SMLocalizer (38 (link)).
+ Open protocol
+ Expand
7

SARS-CoV-2 Spike Protein Binding Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cysteamine (MEA), dithiothreitol (DTT), diamide, and methoxy polyethylene glycol 5000 maleimide (mPEG‐mal5000) were purchased from Merck KGaA (Darmstadt, Germany). C4‐GSH was synthesized by Gluos Srl (Urbino, Italy).20I‐152 and I‐152SdAc were synthesized as described previously resulting in comparable yields and identical NMR spectra.13, 21Anti S1 antibody, recombinant SARS‐CoV‐2 Spike protein RBD domain (aa 304‐526) as well as HEK293 cells stably expressing the Spike S1 subunit (with D614G mutation) or the RBD domain were a generous gift of Diatheva SRL (Cartoceto, Italy). The proteins were engineered to carry an N‐terminal signal peptide for secretion and a C‐terminal His tag for purification.
SARS‐CoV‐2 Receptor Binding Domain (RBD, GenBank: QHD43416, Sigma‐Aldrich, St. Louis, USA) was used in SPR and spectrometry studies. Recombinant Human Angiotensin‐converting Enzyme 2 (ACE2, Acc.N: Q9BYF1, RayBiotech, Peachtree Corners, USA); Sensor chip CM5, HBS‐EP+ buffer (10 mM HEPES pH 7.4; 150 mM NaCl; 3 mM EDTA; 0.05% P20) and Acetate Buffer pH 5.5 were purchased from Cytiva (Cytiva life sciences, Marlborough, USA).
+ Open protocol
+ Expand
8

Synthesis of Gold Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tetrachloroauric acid (HAuCl4), trisodium citrate (Na3C6H5O7), poly(ethylene glycol) diacrylate (PEGDA, average Mn 700), poly(ethylene glycol) diacrylate (PEGDA, average Mn 2000), poly(ethylene glycol) diacrylate (PEGDA, average Mn 6000), poly(ethylene glycol) diacrylate (PEGDA, average Mn 10,000), 2-hydroxy-2-methylpropiophenone (Darocur 1173), and cysteamine were purchased from Merck KGaA (DE).
+ Open protocol
+ Expand
9

Synthesis of Thermoresponsive Polymeric Hydrogels

Check if the same lab product or an alternative is used in the 5 most similar protocols
N-Isopropylacrylamide (NIPAm), N,N,N′,N′-tetramethylethylenediamine (TEMED), N-tert-butylacrylamide (TBAm), phosphate-buffered saline (PBS), and N,N′-methylenebisacrylamide (BIS) were purchased from Alfa Aesar (USA). Ammonium persulfate (APS) was purchased from Acros (USA), glutaraldehyde (GA) was produced by Amresco (USA), and silica gel, acrylic acid (AAc), 3-aminopropyltriethoxysilane (APTES), HSA, lysozyme, pepsin, bovine serum albumin (BSA), cysteamine, ethanolamine, ethanol, and toluene were obtained from Merck (Germany). Acetone was obtained from VWR Chemicals (USA), and N-(3-aminopropyl) methacrylamide hydrochloride (APM) was purchased from Polysciences, Inc. (USA).
+ Open protocol
+ Expand
10

Optimized Imaging Solution for dSTORM

Check if the same lab product or an alternative is used in the 5 most similar protocols
The imaging solution for dSTORM was prepared as reported. Briefly, the following stock solutions were prepared:

0.1 M Tris supplemented with 20 mM NaCl, pH 8, filtered by 0.02 μm filter (VWR, cat. no. 516-1501), stored at 4°C (2× imaging solution of dSTROM)

25% glucose, stored at 4°C (2.5× imaging solution of dSTORM)

1 M cysteamine (Merck, cat. no. 30070) in 0.36 M HCl, stored at 4°C for no more than 1 week (20× imaging solution of dSTORM)

GOD buffer (24 mM PIPES, 4 mM MgCl2, 2 mM EGTA) at pH 6.8 and filtered by 0.02 μm filter, stored at 4°C

20 mg/mL glucose oxidase from Aspergillus niger (Merck, cat. no. G2133) in GOD buffer, centrifuge filtered with 0.22 μm filter (Merck, cat. no. UFC30GV0S), flash-frozen in liquid nitrogen, stored in −80°C (40× imaging solution of dSTORM)

5 mg/mL catalase (Merck, cat. no. C40) in GOD buffer, centrifuge filtered with 0.22 μm filter (Merck, cat. no. UFC30GV0S), flash-frozen in liquid nitrogen, stored in −80°C (125× imaging solution of dSTORM)

The final working imaging solution for dSTORM contains 0.5 mg/mL glucose oxidase, 40 μg/mL catalase, 50 mM cysteamine, and 10% glucose in 50 mM Tris supplemented with 10 mM NaCl at pH 8. This solution was prepared freshly and immediately before imaging.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!